GlobalData on MSN18h
GSK gains approval in Japan for extended indication of RSV vaccine
GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...
GSK’s Blenrep Nears FDA Review for Myeloma
GlaxoSmithKline (GB:GSK) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now ...
UW-led research links wildfire smoke exposure with increased dementia risk
New research led by the University of Washington found that wildfire smoke is especially hazardous to people's memory health. An analysis of the health care records of 1.2 million Southern California ...
GEN18h
Xiaorong He on Boehringer Ingelheim’s Investments in AI, Broader Applications in Pharma
In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.
PharmiWeb17h
Coulter Partners secures industry-leading Chief Medical Officer for Solu Therapeutics
Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with Solu Therapeutics (Solu) and is pleased to announce the ...
Jefferies Sticks to Their Hold Rating for Genmab A/S (0MGB)
Jefferies analyst Peter Welford maintained a Hold rating on Genmab A/S (0MGB – Research Report) today and set a price target of DKK1,650.00.
Pulmonary Arterial Hypertension Market Is Expected To Reach Revenue Of USD 13.2 Bn By 2033, At 5.6% CAGR: Dimension Market Research.
Advancements and Projections in the Global Pulmonary Arterial Hypertension Market: Insights, Trends, Opportunities, and ...
CMAJ21h
Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2, subcutaneous semaglutide reduced the ...
Dietary Supplement Market Is Evaluated To Expand At 8% CAGR To Reach A Value Of $410.46 Billion By 2034
Growing Adoption of Plant-based and Organic Dietary Supplements among Consumers Contributing to <a target=_blank href= ...
Zacks Small Cap Research on MSN19h
V.MDCX: Medicus Pharma Has Begun Trading on Nasdaq under the ticker MDCX after Completing an IPO in the U.S. The SKNJCT-003 Phase 2 clinical trial continues.
MDCX READ THE FULL V.MDCX RESEARCH REPORT IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq On ...
Pharmaceutical Technology on MSN20h
GSK eyes up combo approval for previously withdrawn myeloma drug
The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.
The Pharma Letter16h
FDA signals progress on the western front for belantamab mafodotin
The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for belantamab ...